Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine infiltration versus intraperitoneal instillation for postoperative symptoms after laparoscopic cholecystectomy
IRCT20230523058263N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain and postoperative nausea and vomiting (PONV) (3 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Postoperative pain, Postoperative nausea and 2 more. Started Feb 2024; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20230523058263N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230523058263N1.